Clinical Trials Sponsored by Miltenyi Biotec GmbH

Total 157 results

Masonic Cancer Center, University of Minnesota
Miltenyi Biomedicine GmbH

Withdrawn

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission

Acute Myelogenous Leukemia

United States
Joseph Antin
Miltenyi Biomedicine GmbH

No longer available

CliniMACS® CD34+ Reagent System for Expanded Access Use

Graft Failure | Delayed Graft Function | Graft-Versus-Host Disease(GVHD) | Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells

United States
JOTEC GmbH

Recruiting

A PMCF Study in Patients With Thoracoabdominal Aortic Aneurysms Treated With E-nside TAAA Multibranch Stent Graft System (INNER-B-APAC)

Thoracoabdominal Aortic Aneurysm

New Zealand, Thailand, Australia
JOTEC GmbH

Recruiting

A Post-Market Clinical Follow-up Study in Patients Treated With Vascular Grafts (FLOWGRAFT)

Vascular Diseases

Germany
Bioeq GmbH

Completed

A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis (VESPUCCI)

Plaque Psoriasis

Poland, Estonia, Ukraine, Georgia
JOTEC GmbH

Terminated

E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (SECURE)

Abdominal Aortic Aneurysm | AAA

France, Germany, Spain, Poland, Switzerland
JOTEC GmbH

Recruiting

EASYII - E-tegra Stent Graft System - Imaging Cohort (EASYII)

Vascular Aneurysm

Netherlands
JOTEC GmbH

Recruiting

Registry in Patients With Aorto-iliac or Iliac Aneurysms (PLIANTII)

Vascular Aneurysm

Germany
JOTEC GmbH

Active, not recruiting

A PMCF Study in Patients With Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated With E-vita OPEN NEO (NEOS)

Aortic Aneurysm | Aortic Dissection

Austria, Germany
Bioeq GmbH

Completed

Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration (MAGELLAN-AMD)

Neovascular Age-related Macular Degeneration

Bulgaria, Italy, Poland, Russian Federation, Hungary, Ukraine, Japan, Israel, Czechia
JOTEC GmbH

Active, not recruiting

Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft (TAILOR)

AAA | Iliac Aneurysm

France
JOTEC GmbH

Completed

Prospective/Retrospective Registry of the E-vita OPEN PLUS Stent Graft System in France (FEOR)

Vascular Diseases

France
Bioeq GmbH

Completed

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration (COLUMBUS-AMD)

Age-related Macular Degeneration (AMD)

France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
JOTEC GmbH

Completed

Post-market Registry in Patients With Iliac Aneurysm Undergoing Endovascular Stenting With the E-liac Stent Graft System

Iliac Aneurysm

Germany, Spain, Poland, Austria
JOTEC GmbH

Completed

A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting (ASSIST)

Type B Aortic Dissection

Germany, Spain, Poland, Italy
JOTEC GmbH

Recruiting

A PMCF Study in Patients With Infrarenal Aortic Aneurysm Treated With the E-tegra Stent Graft System (EASY)

Vascular Aneurysm

Netherlands
JOTEC GmbH

Recruiting

A Study in Patients With Thoracoabdominal Aortic Aneurysm Treated With the E-nside TAAA Multibranch Stent Graft System (INNER-B)

Vascular Aneurysm

Germany
JOTEC GmbH

Recruiting

Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I Dissection (PROTECT)

Aortic Dissection | Intramural Hematoma | Acute DeBakey I Dissection | Acute Type A Dissection

Germany
JOTEC GmbH

Active, not recruiting

Post Market Clinical Follow-Up Study in Patients Treated With the On-X Ascending Aortic Prosthesis (AAP) (ASCEND)

Aortic Valve Disease

United States, Spain, United Kingdom, Germany, Italy
JOTEC GmbH

Active, not recruiting

PMCF Study in Patients With Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated With E-vita OPEN NEO (NEOS-APAC)

Aortic Aneurysm | Aortic Dissection

Thailand, Singapore, Hong Kong, Korea, Republic of, Malaysia, Australia
JOTEC GmbH

Active, not recruiting

Registry in Patients With Thoracoabdominal Aneurysms (CONNECT)

Thoracoabdominal Aneurysm

Germany
F2G Biotech GmbH
Covance

Completed

A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim

Healthy

United Kingdom
F2G Biotech GmbH
Covance

Completed

Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects

Invasive Aspergillosis

United Kingdom
Julie-An M. Talano
Miltenyi Biotec, Inc.

Active, not recruiting

Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device

Hematologic Malignancies

United States
Universitätsklinikum Köln
Hannover Medical School; Miltenyi Biomedicine GmbH; ZKS Köln

Terminated

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19 (ACT-COVID-19)

Moderate COVID-19-infection

Germany
Yae-Jean Kim
Miltenyi Biotec B.V. & Co. KG

Withdrawn

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

Cytomegalovirus Infections

Korea, Republic of
Greenovation Biotech GmbH
FGK Clinical Research GmbH

Completed

Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease

Fabry Disease

Germany
BioNTech Diagnostics GmbH

Completed

Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy

Breast Cancer
BioNTech Diagnostics GmbH

Completed

Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"

Invasive Breast Cancer
Evotec International GmbH

Completed

Blood and Urine Sample Collection From Healthy Volunteers

Healthy

Germany
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Miltenyi Biotec, Inc.

Completed

Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine

Fanconi Anemia

United States
Evotec Neurosciences GmbH
Richmond Pharmacology Limited

Completed

The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function

Human Volunteers

United Kingdom
PHARMENTERPRISES LLC
EURRUS Biotech GmbH

Completed

XC8 in the Treatment of Patients With Bronchial Asthma

Bronchial Asthma

Russian Federation
F2G Biotech GmbH
Celerion Ltd

Completed

Study of Potential for Interaction of Fluconazole With F901318

Invasive Aspergillosis

United Kingdom
NKGen Biotech, Inc.
Affimed GmbH

Terminated

Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers

Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Squamous Cell Carcinoma of Head and Neck | Advanced Solid Tumor | Metastatic Tumor | Refractory Tumor

United States
F2G Biotech GmbH
SimbecRresearch Ltd.

Completed

Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects (ORALMAD)

Invasive Aspergillosis

United Kingdom
F2G Biotech GmbH
Quotient Clinical

Withdrawn

Radiolabelled IV and Oral Metabolism Study of F901318 (ADME)

Invasive Aspergillosis

United Kingdom
F2G Biotech GmbH
Quotient Clinical

Withdrawn

Pharmacokinetics of IV Formulation

Invasive Aspergillosis
F2G Biotech GmbH
Quotient Clinical

Completed

Evaluation of Immediate Release Tablet

Invasive Aspergillosis

United Kingdom
F2G Biotech GmbH
Simbec Research

Completed

F901318 Single Ascending Dose Study in Healthy Male Volunteers

Invasive Aspergillosis

United Kingdom
BioNTech RNA Pharmaceuticals GmbH

Completed

RBL001/RBL002 Phase I Clinical Trial (MERIT)

Melanoma

Austria, Germany
Sciotec Diagnostic Technologies GmbH

Not yet recruiting

Observational Study on the Safety and Efficacy of the Medical Product Fructosin.

Fructose Intolerance

Austria
Zimmer, GmbH

Active, not recruiting

Zimmer POLAR Persona - TKA (EMEA Study)

Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis | Polyarthritis | Severe Knee Pain | Severe Knee Disability

France, Spain, United Kingdom, Austria, Germany, Netherlands
BioNTech RNA Pharmaceuticals GmbH

Completed

IVAC MUTANOME Phase I Clinical Trial

Melanoma

Austria, Germany
Zimmer Biomet
Zimmer, GmbH

Not yet recruiting

DenCT Shoulder Bone Quality Evaluation

Rotator Cuff Tears | Osteoarthritis Shoulder

Japan
Sciotec Diagnostic Technologies GmbH

Completed

Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity

Food Intolerance | Histamine Intolerance

Austria
Zimmer, GmbH

Completed

Anatomical Shoulder™ Inverse/Reverse Study

Cuff-tear Arthropathy

Germany, Belgium, Switzerland, United Kingdom
Zimmer Biomet
Zimmer, GmbH

Active, not recruiting

Sidus(TM) Post Market Clinical Follow-up (PMCF) Study

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Non-inflammatory Degenerative Joint Disease (NIDJD) | Inflammatory Joint Disease (IJD)

Germany, Austria, Italy, France, United Kingdom
Zimmer, GmbH

Terminated

Establish Implant Accuracy With X-PSI Knee System (X-PSI)

Knee Osteoarthritis | Post-traumatic Osteoarthritis

United Kingdom, Germany, Netherlands
Zimmer, GmbH

Completed

iAssist vs. Conventional Instrumentation in Total Knee Arthroplasty

Knee Osteoarthritis | Avascular Necrosis | Post-traumatic; Arthrosis

Spain, Switzerland

Clinical Trials Sponsored by Miltenyi Biotec GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations